课题基金 / 基金详情

BIOENGINEERING-BIOLOGICAL STUDY OF ARTERIAL DISEASE

BIOENGINEERING-BIOLOGICAL STUDY OF ARTERIAL DISEASE
动脉疾病的生物工程生物学研究
批准号:
3348001
负责人:
HARVEY S. BOROVETZ
金额:
$17.49万
依托单位国家:
美国
项目类别:
财政年份:
1985
资助国家:
美国
项目状态:
已结题
起止时间:
1985-09-30 至 1991-09-29

项目摘要

项目成果

HARVEY S. BOROVETZ的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The aim of the proposed renewal project is to further our understanding of the role of hemodynamics in atherogenesis; in particular to elucidate mechanisms by which hemodynam ic/biomechanical forces modulate the transcytotic and cellular responses of the vessel wall. A multidisciplinary research team has joined forces in an integrated approach to accomplish our stated aims. Our research plan is built around a novel and reliable in vitro pulsatile perfusion apparatus which exposes freshly excised animal and human vessels (arteries and veins) to well-defined hemodynamics. An important feature of this device is that hemodynamic parameters (e.g., intraluminal pressure, transmural pressure, pulse pressure, rate of flow, etc.) can be individually varied and the biologic/biomechanical response of the vessel wall studied in detail. It is our hypothesis that the de- livery of defined, realistic hemodynamics in vitro provides an environment in which we are able to study, on a fundamental level, how hemodynamic forces influence molecular and cellular aspects of the disease process. Specific timely questions that our studies will address include: i) why vein grafts may "fail" when sewn into the arterial circulation; in particular which arterial hemodynamic parameter(s) modulate the normal metabolic and cellular response of veins; ii) how cellular metabolism, structure and function are influenced by "high" versus "low" shear stress; iii) whether cytoskeletal adaptation to hemodynamic/biomechanical forces contributes to the characteristicallyfocal nature of atherogenesis in vivo; iv) if hemodynamics initiate extracellular matrix reorganization by altering arterial wall metabolism; v) if hemodynamics (e.g., hypertension) accererates lipid accumulation and cellular metabolism at or adjacent to sites of plaque versus lesion free areas; vi) which cell types are most active in LDL degradation in atherosclerotic and non-atherosclerotic portions of human arteries perfused in vitro and which receptors, if any, are involved in this cellular uptake; and, vii) whether "disease susceptible" versus "disease resistant" arteries differ as a function of the aforementioned parameters in response to hemodynamics. To our best knowledge, this integrated approach in which we systematically vary individual hemodynamic parameters and measure the biologic response of the vessel wall to these hemodynamic variables, is unavailable in other bioengineering protocols and marks s important advance toward understanding the role of hemodynamics an atherogenesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Gordon Research Conference on Assisted Circulation
  • 批准号:
    6669000
  • 项目类别:
  • 资助金额:
    $1.5万
  • 财政年份:
    2003
  • 负责人:
    HARVEY S. BOROVETZ
  • 依托单位:
BIOENGINEERING-BIOLOGICAL STUDY OF ARTERIAL DISEASE
BIOENGINEERING-BIOLOGICAL STUDY OF ARTERIAL DISEASE
BIOENGINEERING-BIOLOGICAL STUDY OF ARTERIAL DISEASE
海外基金